 |
NICE says ibrutinib now available for routine NHS use Related items from OnMedica 75% of reappraised CDF drugs approved for NHS MPs slam government for its poor management of Cancer Drugs Fund NHS cancer patients still denied treatments available in other countries Study shows huge global variation in cancer drug costs NICE green lights new cancer drugs for NHS |
Friday, 25 November 2016
Regulator reverses decision on leukaemia drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment